Literature DB >> 34895907

Commentary: Cardiothoracic residency interviews during the coronavirus disease 2019 (COVID-19) pandemic: Time to recalibrate and reconnect virtually.

Robert E Merritt1.   

Abstract

Entities:  

Year:  2021        PMID: 34895907      PMCID: PMC8616687          DOI: 10.1016/j.jtcvs.2021.11.059

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   6.439


× No keyword cloud information.
Robert E. Merritt, MD The COVID-19 pandemic has significantly altered the cardiothoracic residency interview process. Programs will have to recalibrate their interview process and embrace the virtual interview platform. See Article page XXX. The coronavirus disease 2019 (COVID-19) pandemic has disrupted most aspects of daily living since March 2020. The social distancing and mitigation of coronavirus transmission policies have forced cardiothoracic surgery residency programs to quickly pivot from in-person interviews to a completely virtual format. Unfortunately, many cardiothoracic residency programs were not prepared to optimally orchestrate effective and informative virtual interviews to adequately showcase their residency program strengths in the best possible light. A survey by the Thoracic Education Cooperative Group revealed that 96% of the cardiothoracic surgery residency applicants who interviewed during the 2019 to 2020 interview season favored the in-person component of the interview process. The most lackluster components of the initial cardiothoracic residency virtual interview process were the description of the culture of the programs and the lifestyle of the surrounding communities in which the residency programs are located. Given the substantial amount of cost savings and fewer days missed from work by cardiothoracic surgery residency candidates, there will certainly be enough impetus for optimizing and maintaining the virtual interview platform in the foreseeable future.2, 3, 4 Taylor and colleagues have provided some potential areas of improvement for traditional cardiothoracic residency virtual interviews. They reported that only 7% of cardiothoracic surgery residency candidates, who were surveyed after the 2020 to 2021 Match, preferred the in-person interview format and 87% of the respondents had a favorable virtual interview experience. The challenge is, however, that only 50% of the survey respondents felt that they were able to fully evaluate residency programs with the virtual interview format. This should be a call to action for current cardiothoracic residency programs who are trying to recruit the best and the brightest residents during the COVD-19 pandemic and beyond. The disconnect between the favorable view of virtual interviews by applicants and the inability to decipher important residency program characteristics underscores the important need for the adoption of new changes to improve the virtual interview experience for cardiothoracic residency candidates. Improving and expanding the cardiothoracic training program's website is one high-yield upgrade that could better display faculty profiles, current and past residents' profiles, case logs, and didactic curriculum information. In addition, virtual tours and interviews with current cardiothoracic residents would be another high-yield component of the virtual interview experience that provides cardiothoracic residency candidates the best insight into the culture of the program and the daily experiences of current cardiothoracic surgery residents. A major source of training program information regarding the amount of trainee autonomy, operative experience, culture, and quality of life come from informal interactions with current residents. These candid encounters between the current cardiothoracic residents and applicants are probably the most important components of the interview process; therefore, cardiothoracic programs will have to preserve these current trainee–applicant interactions in the virtual interview process. In the foreseeable future, the challenge for cardiothoracic residency programs is to figure out what factors are important to applicants when ranking programs and determine how to best showcase the most beneficial program characteristics in a virtual interview platform.
  7 in total

1.  Efficacy of Videoconference Interviews in the Pediatric Surgery Match.

Authors:  Nicole M Chandler; Cristen N Litz; Henry L Chang; Paul D Danielson
Journal:  J Surg Educ       Date:  2018-09-12       Impact factor: 2.891

2.  The Burden of the Fellowship Interview Process on General Surgery Residents and Programs.

Authors:  Shawna L Watson; Robert H Hollis; Lasun Oladeji; Shin Xu; John R Porterfield; Brent A Ponce
Journal:  J Surg Educ       Date:  2016-07-11       Impact factor: 2.891

3.  Interviews During the Pandemic: A Thoracic Education Cooperative Group and Surgery Residents Project.

Authors:  Melissa Taylor; Tyler Wallen; J Hunter Mehaffey; Ali Shirafkan; Alexander A Brescia; Kirsten Freeman; Clauden Louis; Justin Watson; Ikenna Okereke
Journal:  Ann Thorac Surg       Date:  2021-03-25       Impact factor: 4.330

4.  Applicant perception of virtual interviews in cardiothoracic surgery: A Thoracic Education Cooperative Group Study.

Authors:  Melissa Taylor; Kirsten Freeman; J Hunter Mehaffey; Tyler Wallen; Ikenna C Okereke
Journal:  J Thorac Cardiovasc Surg       Date:  2021-12-07       Impact factor: 5.209

5.  Urology Residency Applications in the COVID-19 Era.

Authors:  Alexander P Kenigsberg; Roger K Khouri; Amy Kuprasertkul; Daniel Wong; Vishnu Ganesan; Gary E Lemack
Journal:  Urology       Date:  2020-06-17       Impact factor: 2.649

Review 6.  How Has COVID-19 Affected the Costs of the Surgical Fellowship Interview Process?

Authors:  Jennifer Tseng
Journal:  J Surg Educ       Date:  2020-05-20       Impact factor: 2.891

Review 7.  Showcasing Your Cardiothoracic Training Program in the Virtual Era.

Authors:  David B Nelson; Peter T White; Ravi Rajaram; Mara B Antonoff
Journal:  Ann Thorac Surg       Date:  2021-01-23       Impact factor: 5.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.